Could the New Name for PCOS Help Women Get Diagnosed Quicker? Experts Weigh In on the Change
For decades, women with PCOS have bounced between specialists, waited years for answers and been told their ultrasound looked “normal” even as symptoms piled up. A new name for the disorder — and a broader definition behind it — is meant to change that.
Polycystic Ovary Syndrome has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), and researchers say the shift could finally push doctors to recognize the condition as a whole-body metabolic and hormonal disease rather than a gynecological one. For patients, that could mean a faster diagnosis and treatment that targets the root of the disorder instead of one symptom at a time.
For more information: PCOS Has Been Renamed: Everything to Know About the New Name PMOS and Why It Was Changed
Why PCOS Was Renamed PMOS
The change was driven by research published in The Lancet, led by Dr. Helena Teede, an endocrinologist and professor of Women’s Health at Monash University in Australia. The team surveyed 14,360 patients and multidisciplinary health professionals from every world region, asking whether the old name was accurate or harmful and what concepts a new name should include.
The result: a term that leads with hormones and metabolism, not cysts.
“It is fantastic that the new name now leads with hormones and recognizes the metabolic dimension of the condition,” said Rachel Morman, Chair of Verity PCOS UK, in a press release from the Endocrine Society. “This shift will reframe the conversation and demand that it is taken as seriously as the long-term, complex health condition it is. Despite decades of tireless advocacy to improve awareness, we recognized that the risk of change would be worth the reward.”
How Long Diagnosis Has Taken — and Why
The diagnosis gap has been one of the most painful aspects of the condition. A 2017 study of 1,385 women published in the Journal of Clinical Endocrinology & Metabolism found that about one in three patients waited more than two years for a diagnosis, and only 35.2% were satisfied with their diagnosis experience or the information they received.
Dr. Rekha Kumar, an endocrinologist at NewYork-Presbyterian/Weill Cornell Medical Center, said several factors have kept women undiagnosed.
“There are several layers to this. First, many women were told ‘your ultrasound is normal, you don’t have PCOS,’ when in fact ovarian health is just one component of a diagnosis, and not even the most important one,” Kumar said. “Second, the condition looks different in different women. A lean woman with irregular periods and no obvious excess hair growth doesn’t fit the stereotype, so she might get missed.”
“Third, when the condition is framed as a gynecological problem, it tends to be managed by gynecologists alone, and the metabolic workup evaluating insulin resistance, lipids and glucose tolerance gets deprioritized,” Kumar continued.
Dr. Christina Boots, associate professor of obstetrics and gynecology at Northwestern’s Feinberg School of Medicine, told CNN that recognizing the wider scope could also unlock funding: “Women’s health is notoriously underfunded. Recognizing that it really spans not just reproductive issues, but mental health and metabolic health as well, maybe will help enhance the number of dollars and the number of studies that are to understand it and treat it.”
What the New Name Means for Treatment
The rename also targets treatment that has long been piecemeal — birth control for acne, fertility drugs for pregnancy, with the metabolic picture left untouched.
“I hope so. Right now, treatment for PMOS is often narrowly oriented around the most obvious symptoms. For example, if a patient wants to get pregnant, her treatment addresses that. If she comes in with acne, she gets a birth control pill,” Kumar said. “In my practice, I approach PMOS as a metabolic condition first. That means lifestyle medicine, nutritional strategies, and, when appropriate, medication to control blood sugar levels and increasingly GLP-1 receptor agonists, which have shown real promise in improving both the metabolic picture and optimizing fertility.”
Dr. Wright Bates, chair of the Department of OB-GYN at Baylor Scott and White, told KCEN-TV the stakes are high: “The thing that’s really been missed and is scary is it affects your metabolism so much that it can make you unhealthy and even die early because you get heart disease and peripheral vascular disease, problems with your liver, all the things that are missed if you just focus on a cyst.”
Dr. Steven Vasilev, gynecologic oncologist and founder of the Lotus Endometriosis Institute, told Healthline the new name “should help push research toward the metabolic and hormonal roots of the disease — insulin resistance, androgen excess, and chronic inflammation — rather than focusing on ovarian cysts.”
What to Do if You Think You Have PMOS
Kumar’s advice for patients: don’t accept a clean ultrasound as the final word.
“Advocate for yourself,” she said. “Specifically, ask your clinician about a workup for PMOS. Don’t let ‘your ultrasound looks fine’ be the end of the conversation. A proper evaluation includes a detailed menstrual history, assessment for clinical signs of androgen excess, serum androgens, fasting insulin and glucose, a lipid panel, and an ultrasound in combination with your whole health picture.”
“I would encourage women to seek out an endocrinologist, an internist with metabolic medicine expertise, or a reproductive endocrinologist who thinks beyond fertility alone. And if you don’t feel heard, find someone else. This condition has a long history of being dismissed, and women deserve rigorous, comprehensive care,” she added.
This article was created by content specialists using various tools, including AI.
This story was originally published May 20, 2026 at 11:00 AM with the headline "Could the New Name for PCOS Help Women Get Diagnosed Quicker? Experts Weigh In on the Change."
